## Session overview Tesla led the gainers in the after-midnight session, rising about 5.51%, followed by SLB up roughly 4.83%, QCOM up about 3.83%, BSX up around 3.12%, and XOM higher by approximately 2.71%. On the downside, BABA dropped about 4.10%, with

Verdict: Tesla's entry setup is close, but a margin collapse says wait

This idea could not be evaluated as a backtest — the compiled strategy could not produce an evaluable test window — so this verdict scores the live setup, not a validated track record. The strongest case for the trade is momentum plus a genuine fundamental inflection: TSLA's Q2 2026 revenue hit $28.2B, up 26.1% sequentially, with net income more than doubling to $1.11B, and price at $353.95 sits just $4.77 below the EMA (50) at $358.72 with RSI (14) at 34.0, well inside the entry condition. The strongest case against is the quality of that quarter: free cash flow swung from +$1.44B to -$1.09B, gross margin compressed from 21.1% to 16.8%, operating margin fell from 4.2% to 1.4%, and the share count grew 5.2% to 3.95B in a single quarter — plus insider filings for the period ended June 30, 2026 show net open-market selling of about $12.4M across 19 holders. The decisive fact would be the next quarterly filing confirming the deterioration was capex-driven rather than demand-driven, or the hourly close crossing above roughly $358.7 while RSI stays below 55. Until one of those confirms, the evidence supports patience, not entry.

Trade now: TSLA is $4.77 from the trigger line

The setup is a long Tesla trade on the hourly chart, waiting for the close to cross above the 50-period EMA while RSI (14) sits at or below 55. As of the latest reading, TSLA closed at $353.95 against an EMA (50) of $358.72 — a gap of $4.77, roughly 1.3% — so the price condition is near but not met. RSI (14) is at 34.0, comfortably inside the at-or-below-55 requirement, so momentum is not the blocker; price is. One factual scope note: the compiled strategy could not produce an evaluable test window, so there is no historical performance figure behind this exact rule set — the plan below is built from live levels, not a track record. No robust parameter setup was established either, so the thresholds quoted here are the frozen rules as published. If the entry triggers, the working risk parameters are a hard stop at a 2.5% loss on the position and a take profit at a 5.0% gain — an effective reward-to-risk of about 2:1. The signal-side exits also matter: a close at or above the first resistance level ($356.26) would take profit, a break below the second support level ($342.63) would cut the trade, and RSI rising above 75 would signal an overbought exit. Position sizing is fixed-risk, capped at 25% of the account per position. What "wait" means concretely: no position until TSLA's hourly close crosses above roughly $358.7 with RSI still below 55. If price stalls below the EMA and RSI climbs back above 55, the setup expires rather than chases — re-evaluate on the next reset.

The breadth behind the gainers' column has some fundamental support

A scope note first: this idea could not be evaluated as a backtest — the compiled strategy could not produce an evaluable backtest window — so what follows scores the decision dimensions the data does support, not a validated signal. Within that scope, the session rotation described in the idea is not random noise. Tesla's roughly 5.5% pop came alongside a real fundamental inflection: second-quarter 2026 revenue of $28.2B, up 26.1% from the prior quarter, with net income more than doubling to $1.11B and the net margin recovering to 3.9% from 2.1%. Free cash flow did flip negative at -$1.09B, but operating cash flow rose 19.3% to $4.7B, which argues the quarter's deterioration was capex-driven rather than demand-driven. The energy names the idea flagged as rotating into the gainers' column also carry numbers. SLB grew revenue 2.9% sequentially to $8.97B, lifted free cash flow from $144M to $900M (a 525% improvement), and grew operating cash flow 179% to $1.36B, all while its dividend has compounded at a steady 3.5–4% annual pace since 2021. XOM, up about 2.7% in the session, still delivered $85.1B in Q1 2026 revenue (up 3.4% sequentially) and pays a dividend raised or held nearly every year since 2020, with the 2026 annual total of $3.09 per share above 2025's $4.00 on a split-adjusted basis. Boston Scientific — up 3.1% in the session — has the cleanest fundamental picture of the ten names: fiscal 2025 revenue growth of 19.9% to $20.1B, a 69.0% gross margin, $3.66B in free cash flow, and return on equity of 11.9%, all landing in the top quintile of its health care peer set. Insider filings for the quarter ended June 30, 2026 show the only net open-market buying across the group: +$10.0M from seven insiders. If you want one name where the tape, the fundamentals, and the insider signal agree, it is BSX. Finally, the idea's core claim — that pressure broadened beyond semis into a genuine rotation — is consistent with what the fundamentals show underneath. QCOM's June-quarter revenue of $9.95B was down 6.2% sequentially and net income fell 72.8%, so the chip bounce off the prior night's LRCX/NVDA/AMD losses was never supported by the latest numbers. Meanwhile Alibaba's fiscal 2026 operating margin collapsed from 14.1% to 4.9% and operating cash flow halved to $11.0B. The sellers in BABA (down 4.1%) and NIO (down 3.2%) were not fighting strong tape; they were pricing deteriorating fundamentals.

What could break the rotation

The ownership tape is the clearest headwind. Across the June 30, 2026 filings, eight of the ten names show net open-market insider selling, and the sellers were not small: -$70.8M at BABA, -$42.9M at AMZN, -$25.7M at BKNG, -$12.4M at TSLA, -$6.9M at QCOM, and -$5.5M at SLB. The idea's bullish rotation into energy and travel — SLB, XOM, BKNG — has insiders doing the opposite of buying in two of those three. Only BSX (+$10.0M, seven buyers) breaks the pattern. Note also the coverage state: these are deadline-passed reports for the quarter ended June 30, 2026, so they describe positions as of mid-2026, not current behavior. The idea's lead gainer is its most fragile fundamental story. Tesla's Q2 2026 free cash flow swung from +$1.44B to -$1.09B (a 176% deterioration), the operating margin compressed from 4.2% to 1.4%, and the gross margin fell from 21.1% to 16.8%. Meanwhile the share count grew 5.2% in a single quarter to 3.95B — dilution the market seemed willing to ignore during a 5.5% session. A rally built on a margin collapse and an expanding share base is the kind that reverses on the next guidance print. For scale, these mega-caps regularly move 3–5% in a single after-midnight session (AMZN fell 2.5% the same night it had gained ~4.0% the prior session), so a single session's direction is a weak predictor. Several of the other gainers are more expensive than the tape suggests. QCOM's June quarter shows net income down 72.8% to $2.0B, net margin compressed from 69.5% to 20.1%, operating cash flow down 59.5%, and free cash flow down 74.2% to $495M — a deteriorating quarter wearing a +3.8% session. XOM's most recent quarter (period ended March 31, 2026) shows net income down 35.7% to $4.18B, free cash flow down 57.3% to $2.24B, and return on equity of just 1.6%. Even BKNG, with its 99th-percentile free cash flow rank, carries deeply negative book equity (about -$5.6B at fiscal 2025 year-end) and a dividend that was cut roughly 34% annually — $0.84 per share in 2026 versus $1.54 in 2025. Finally, the dividend and profitability screens argue this is a mixed bag, not a quality rotation. NIO remains deeply unprofitable (a -$2.14B net loss, negative 3.59 return on equity, current ratio just under 1.0) and its annual share count has climbed over 10% in a year. BILI's turnaround to $171M in net income is real but came with a 32.6% jump in its debt-to-equity ratio, and its ownership filing shows only a single reporter — too thin a sample to read either way. With no robust parameter setup established (the strategy could not be evaluated, so no variant was recommended) and the idea itself direction-neutral, the burden of proof sits with the rotation, and the insider and cash-flow evidence does not clearly carry it.

Company context

### AMZN **Ownership and insiders.** For the period ending 2026-06-30, 25 reporting holders were counted holding 31248860 reported shares. Insider filings indicate net open-market selling, netting US$-42947271.7. Coverage: Deadline Passed. **Management.** Mr. Andrew R. Jassy is identified as chief executive. Mr. Andrew R. Jassy is listed as President, CEO & Director, with reported total pay of US$2.1M for fiscal 2025. Source: [Yahoo Finance quoteSummary](https://finance.yahoo.com/quote/AMZN/profile), retrieved 2026-09-05T14:44:33.05+00:00. **Dividends.** The provider's ten-year corporate-action history contains no cash dividend payments. Source: [Yahoo Finance corporate actions](https://finance.yahoo.com/quote/AMZN/history?filter=div), retrieved 2026-09-05T14:44:33.05+00:00. **Fundamental changes.** Latest filed comparisons: - Debt to equity: 23.3% on 2026-06-30 versus 26.9% on 2026-03-31 (-13.3%) - Free cash flow: -8.8B on 2026-06-30 versus -18.2B on 2026-03-31 (-51.5%) - Gross margin: 52.2%…

Scores

• Conviction score breakdown: 48
• Thesis support: 55
• Trade readiness: 50
• Risk quality: 45
• Fundamentals trend: 40

Watch items

• TSLA — Hourly close vs EMA (50)
• TSLA — RSI (14)
• TSLA — RSI (14) overheat
• TSLA — Nearest resistance
• TSLA — Second support level
• TSLA — Next quarterly earnings
• TSLA — Insider ownership filings